Business & Finance
Aeolus Pharmaceuticals reports loss of $0.01 per share
Published in Law and Health Weekly, January 20th, 2007
The company reported a net loss of $214,000, or $0.01 per share, compared to a loss of $1,653,000, or $0.12 per share, for the 3 months ended September 30, 2005, a decrease of 87%. Results for the 3 months ended September 30, 2006 included a $1,211,000 gain from the decrease in the fair value of common stock warrants. For its fiscal year ended September 30, 2006, the company reported a net loss attributable to common shareholders of $5,809,000, or $0.31 per share, for the fiscal year ended September 30, 2006, compared to a loss of $6,905,000, or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Awards
Neuropharma receives Frost & Sullivan International Excellence in Technology award - Behavior
Research from Creighton University, Department of Psychology provides new data on behavior - Business & Finance
Genmab discloses details of the issue of shares to GlaxoSmithKline - Business Update
Advancis closes private placement of common equity, files application for Pulsys - Business Update
Analytical Spectral Devices launches portable drug anti-counterfeiting technology - Business Update
Anchen announces approval of generic version of Wellbutrin XL - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
